Waalen J - Search Results

1

Hereditary hemochromatosis: screening and management.

Waalen J, Beutler E. Waalen J, et al. Curr Hematol Rep. 2006 Mar;5(1):34-40. Curr Hematol Rep. 2006. PMID: 16537044 Review.

2

Genetic screening for low-penetrance variants in protein-coding genes.

Waalen J, Beutler E. Waalen J, et al. Annu Rev Genomics Hum Genet. 2009;10:431-50. doi: 10.1146/annurev.genom.9.081307.164255. Annu Rev Genomics Hum Genet. 2009. PMID: 19715441 Review.

3

Screening for hemochromatosis by measuring ferritin levels: a more effective approach.

Waalen J, Felitti VJ, Gelbart T, Beutler E. Waalen J, et al. Blood. 2008 Apr 1;111(7):3373-6. doi: 10.1182/blood-2007-07-102673. Epub 2007 Nov 19. Blood. 2008. PMID: 18025154 Free PMC article.

4

Chronic inflammation does not appear to modify the homozygous hereditary hemochromatosis phenotype.

Beutler E, Waalen J, Gelbart T. Beutler E, et al. Among authors: waalen j. Blood Cells Mol Dis. 2005 Nov-Dec;35(3):326-7. doi: 10.1016/j.bcmd.2005.08.003. Epub 2005 Sep 9. Blood Cells Mol Dis. 2005. PMID: 16154780

5

The penetrance of hereditary hemochromatosis.

Waalen J, Nordestgaard BG, Beutler E. Waalen J, et al. Best Pract Res Clin Haematol. 2005 Jun;18(2):203-20. doi: 10.1016/j.beha.2004.08.023. Best Pract Res Clin Haematol. 2005. PMID: 15737885 Review.

6

Ferroportin 1 (SCL40A1) variant associated with iron overload in African-Americans.

Beutler E, Barton JC, Felitti VJ, Gelbart T, West C, Lee PL, Waalen J, Vulpe C. Beutler E, et al. Among authors: waalen j. Blood Cells Mol Dis. 2003 Nov-Dec;31(3):305-9. doi: 10.1016/s1079-9796(03)00165-7. Blood Cells Mol Dis. 2003. PMID: 14636643

7

Penetrance of hemochromatosis.

Waalen J, Felitti V, Gelbart T, Ho NJ, Beutler E. Waalen J, et al. Blood Cells Mol Dis. 2002 Nov-Dec;29(3):418-32. doi: 10.1006/bcmd.2002.0596. Blood Cells Mol Dis. 2002. PMID: 12678056

8

Haematological effects of the C282Y HFE mutation in homozygous and heterozygous states among subjects of northern and southern European ancestry.

Beutler E, Felitti V, Gelbart T, Waalen J. Beutler E, et al. Among authors: waalen j. Br J Haematol. 2003 Mar;120(5):887-93. doi: 10.1046/j.1365-2141.2003.04215.x. Br J Haematol. 2003. PMID: 12614226

9

Prevalence of hemochromatosis-related symptoms among individuals with mutations in the HFE gene.

Waalen J, Felitti V, Gelbart T, Ho NJ, Beutler E. Waalen J, et al. Mayo Clin Proc. 2002 Jun;77(6):522-30. doi: 10.4065/77.6.522. Mayo Clin Proc. 2002. PMID: 12059121

10

Rationale and design of a home-based trial using wearable sensors to detect asymptomatic atrial fibrillation in a targeted population: The mHealth Screening To Prevent Strokes (mSToPS) trial.

Steinhubl SR, Mehta RR, Ebner GS, Ballesteros MM, Waalen J, Steinberg G, Van Crocker P Jr, Felicione E, Carter CT, Edmonds S, Honcz JP, Miralles GD, Talantov D, Sarich TC, Topol EJ. Steinhubl SR, et al. Among authors: waalen j. Am Heart J. 2016 May;175:77-85. doi: 10.1016/j.ahj.2016.02.011. Epub 2016 Feb 23. Am Heart J. 2016. PMID: 27179726 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results